A US appeals court on Wednesday temporarily suspended an order blocking the French pharmaceutical group Sanofi and its American partner Regeneron from selling their anti-cholesterol drug Praluent.
A US appeals court on Wednesday temporarily suspended an order blocking the French pharmaceutical group Sanofi and its American partner Regeneron from selling their anti-cholesterol drug Praluent.